Table II.
Patient outcomes between nonCOVID-19 ICU patients and COVID-19 ICU patients. Categorical variables are presented as total number with percentages; nonnormally distributed continuous variables are expressed as median with IQR
| Pre-COVID 2019 N = 249 | COVID-19 N = 249 | P-value | |
|---|---|---|---|
| Patient Outcomes | |||
| Hospital Length of Staya | 3 (2, 6) | 9 (4,14) | <0.001 |
| Blood Transfusion (%) | 40 (16%) | 56 (22.5%) | 0.069 |
| Gangrene (%) | 1 (0.4%) | 12 (4.8%) | 0.002 |
| Gangrene Lower (%) | - | - | 0.017 |
| Gangrene Lower - None | 248 | 237 | - |
| Gangrene Lower – Left Lower Extremity | 0 | 4 | - |
| Gangrene Lower – Right Lower Extremity | 1 | 3 | - |
| Gangrene Lower – Bilateral Lower Extremities | 0 | 5 | - |
| Gangrene Upper (%) | 0 | 2 | 0.249 |
| Mortality (%) | 29 (11.6%) | 103 (41.4%) | <0.001 |
| Major Amputation (%) | 0 | 4 (1.6%) | 0.045 |
| Minor Amputation (%) | 0 | 0 | 0 |
| Revascularization (%) | 2 (0.8%) | 5 (2%) | 0.253 |
| Hospital Anticoagulation | |||
| Timing of Anticoagulation | - | - | 0.212 |
| Not Started (%) | 228 (91.6%) | 227 (91.2%) | - |
| Admission (%) | 21 | 19 | - |
| Hospital Day Two and Onward (%) | 0 | 3 | - |
| Contraindications to Anticoagulation (%) | 8 (3.2%) | 12 (4.8%) | 0.361 |
Significant differences are bolded.
a
Analyzed with nonparametric Mann Whitney U test. All other comparisons were analyzed with chi-squared test.